Literature DB >> 19344742

Courses of aripiprazole-associated tardive dyskinesia: report of two cases.

Liang-Jen Wang, Shao-Chun Ree, Chih-Ken Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19344742     DOI： 10.1016/j.pnpbp.2009.03.023

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN： 0278-5846            Impact factor:   5.067


× No keyword cloud information.
  6 in total

1.  Pharmacological blockade of dopamine D2 receptors by aripiprazole is not associated with striatal sensitization.

Authors:  Beryl Koener; Stéphanie Goursaud; Morgane Van De Stadt; André-Guilhem Calas; Anne P Jeanjean; Jean-Marie Maloteaux; Emmanuel Hermans
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-01       Impact factor: 3.000

2.  A case of aripiprazole induced tardive dyskinesia in a neuroleptic-naïve patient with two years of follow up.

Authors:  Rakesh Goyal; Salam Hemabati Devi
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-04-24       Impact factor: 2.582

3.  Tardive dyskinesia: treatment with aripiprazole.

Authors:  Na-Ri Kang; Moon-Doo Kim
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-04-30       Impact factor: 2.582

4.  The role of P-glycoprotein in CNS antihistamine effects.

Authors:  Silke Conen; Eef L Theunissen; Annemiek Vermeeren; Peter van Ruitenbeek; Peter Stiers; Mitul A Mehta; Stefan W Toennes; Johannes G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2013-04-07       Impact factor: 4.530

5.  Aripiprazole-induced Tardive Dyskinesia in 13 Years Old Girl Successfully Treated with Biperiden: A Case Report.

Authors:  Marco Lamberti; Gabriella Di Rosa; Francesca Cucinotta; Erica Pironti; Cecilia Galati; Antonella Gagliano
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-08-31       Impact factor: 2.582

6.  Aripiprazole in Tardive Dyskinesia: Is it a Safe Choice?

Authors:  Nimisha Doval; Soumitra Das; Vikas Moun
Journal:  J Neurosci Rural Pract       Date:  2017 Apr-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.